- "Setting the Standard in Testing and Awareness"
- Since 2000, Screen’s test battery, the Computer-Administered Neuropsychological Screen for Mild Cognitive Impairment (CANS-MCI), has led the way in early detection and awareness of impending dementia.
- The CANS-MCI continues to meet high scientific and practitioner standards (validity, sensitivity, specificity, clarity of reports, and unique ease of use for doctors and patients). Its exceptional value is evident in pre-diagnostic early warnings and in longitudinal tracking of the changes in cognitive ability most predictive of Alzheimer's.
- In a recently published study that reviewed computer-based test batteries used to detect cognitive decline in the elderly, researchers gave the CANS-MCI the top overall score in every category and a special mention for exceptional user friendliness.*
* Wild et al, Alzheimer's & Dementia, 2008.
Why Test?
Alzheimer’s and other forms of dementia may not yet be defeated, but they can be managed.
Too often, medical professionals, families and caregivers are not given the timely information they need to begin medication management and to plan for long-term care.
Not only can Screen help with early awareness of cognitive decline, it can also monitor and document changes in the cognitive state.
The CANS-MCI is a key strategic tool in helping Physicians help families. Contact Screen and learn why we are leading the way in detection and diagnostics.